Kate Brain

Professor of Health Psychology
Cardiff University

Chairing: Inequalities in cancer detection and diagnosis

Carmen Guerra

Ruth C. and Raymond G. Perelman Professor of Medicine
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Chairing: Inequalities in cancer detection and diagnosis

Sam Janes

Director of Medicine
University College London (UCL)

Chairing: Understanding pre-cancers to enable early detection

Irene Ghobrial

Professor of Medicine
Dana-Farber Cancer Institute

Chairing: Understanding pre-cancers to enable early detection

Yoryos Lyratzopoulos

Professor of Cancer Epidemiology
University College London (UCL)

Chairing: Risk stratification to inform early detection

Sapna Syngal

Director of Research, Division of Cancer Genetics and Prevention, Director of Strategic Planning for Prevention and Early Cancer Detection, Dana-Farber Cancer Institute
Leader, Cancer Risk, Prevention, and Early Detection Program, Dana-Farber/Harvard Cancer Center, Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute

Chairing: Risk stratification to inform early detection

Matthew Thompson

Professor, University of Washington Department of Family Medicine & Clinical Research Scientist
Google Inc, and University of Washington

Chairing: Multicancer early detection – beyond ctDNA

Claude Chelala

Professor of Bioinformatics
Barts Cancer Institute, Queen Mary University of London

Chairing: Multicancer early detection – beyond ctDNA

Jon Emery

Herman Professor of Primary Care Cancer Research
University of Melbourne

Chairing: Panel – What lessons did we learn from COVID-19 that can be applied to early cancer detection?

Larry Kessler

Professor, Health Systems and Population Health
University of Washington/MCED Consortium

Chairing: Panel – The health economics of early detection

David Crosby

Head of Prevention and Early Detection Research
Cancer Research UK

Chairing: ‘We need to shift early detection of cancer away from medical practices and hospitals and into the community’ Great Debate & ‘All cancer screening must be reserved for ‘high risk’ population’ Great Debate